BioNexus Gene Lab Corp. Appoints Angeline Chong as New Chief Financial Officer, Succeeding Su-Leng Tan Lee

Reuters
06-24
<a href="https://laohu8.com/S/BGLC">BioNexus Gene Lab Corp.</a> Appoints Angeline Chong as New Chief Financial Officer, Succeeding Su-Leng Tan Lee

BioNexus Gene Lab Corp. has appointed Ms. Chong Set Fui (Angeline) as the new Chief Financial Officer and Principal Financial Officer, effective June 17, 2025. Ms. Chong brings over 25 years of financial leadership experience, previously serving as CFO of Avillion Berhad. She will also serve as CFO of the company's subsidiary, MRNA Scientific Sdn. Bhd. Concurrently, Mr. Su-Leng Tan Lee has stepped down from his role as acting CFO and Principal Financial Officer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNexus Gene Lab Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-25-004754), on June 23, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10